isoflurane has been researched along with vanoxerine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harada, N; Kakiuchi, T; Nakanishi, S; Nishiyama, S; Ohba, H; Sato, K; Tsukada, H | 1 |
Fukumoto, D; Harada, N; Kakiuchi, T; Ohba, H; Tsukada, H | 1 |
Andersson, DR; Nissbrandt, H; Shahabi, HN | 1 |
3 other study(ies) available for isoflurane and vanoxerine
Article | Year |
---|---|
Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain.
Topics: Anesthesia, Inhalation; Animals; Brain; Carbon Radioisotopes; Carrier Proteins; Cocaine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Isoflurane; Kinetics; Macaca mulatta; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; Nerve Tissue Proteins; Piperazines; Receptors, Dopamine D2; Time Factors; Tomography, Emission-Computed; Wakefulness | 1999 |
Potential of [(18)F]beta-CFT-FE (2beta-carbomethoxy-3beta-(4-fluorophenyl)-8-(2-[(18)F]fluoroethyl)nortropane) as a dopamine transporter ligand: A PET study in the conscious monkey brain.
Topics: Anesthetics; Animals; Brain; Carbon Radioisotopes; Consciousness; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fluorine Radioisotopes; Humans; Isoflurane; Ketamine; Ligands; Macaca mulatta; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Nortropanes; Piperazines; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Cytochrome P450 2E1 in the substantia nigra: relevance for dopaminergic neurotransmission and free radical production.
Topics: 4-Butyrolactone; Adrenergic alpha-Agonists; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Enzyme Inhibitors; Extracellular Space; Free Radicals; GABA Modulators; Hydroxybenzoates; In Vitro Techniques; Isoflurane; Ketamine; Male; Microdialysis; Parabens; Piperazines; Rats; Rats, Sprague-Dawley; Reserpine; Substantia Nigra; Synaptic Transmission; Tetrodotoxin; Xylazine | 2008 |